🇺🇸 abiraterone acetate with Methylprednisolone in United States

FDA authorised abiraterone acetate with Methylprednisolone on 22 May 2018

Marketing authorisation

FDA — authorised 22 May 2018

  • Application: NDA210308
  • Marketing authorisation holder: SUN PHARM
  • Local brand name: YONSA
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Frequently asked questions

Is abiraterone acetate with Methylprednisolone approved in United States?

Yes. FDA authorised it on 22 May 2018.

Who is the marketing authorisation holder for abiraterone acetate with Methylprednisolone in United States?

SUN PHARM holds the US marketing authorisation.